Are Mesenchymal Stem Cells a Promising Treatment for COVID-19?
As the first clinical data become available on treating coronavirus patients with the cells, scientists are equivocal about the rationale for the intervention.
Are Mesenchymal Stem Cells a Promising Treatment for COVID-19?
Are Mesenchymal Stem Cells a Promising Treatment for COVID-19?
As the first clinical data become available on treating coronavirus patients with the cells, scientists are equivocal about the rationale for the intervention.
As the first clinical data become available on treating coronavirus patients with the cells, scientists are equivocal about the rationale for the intervention.
Researchers unravel the mystery of epithelial to mesenchymal transition in acute lymphoblastic leukemia with co-culture techniques, CRISPR-screening, and RNA sequencing.
Using a 3D culture system that imitates fatty tissue, researchers developed a simpler process to study mesenchymal stem cell aging and tissue regeneration.
Scientists uncover the promise of mesenchymal stem cells (MSCs), also known as medicinal signaling cells, to modulate the immune system and regenerate tissue.
Critics say the misleading term actually refers to a heterogeneous population of cells, including possible tissue-specific progenitor cells and nonstem cells all lumped together.